SCHEMBL25328693

SCHEMBL25328693

CCCCOc1c(CC)c(CC)c(O)c(CC)c1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.41
NR5A1 Q13285 1/20 0.41
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
ESR1 P03372 7/20 0.37
TLR4 O00206 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP19A1 P11511 1/20 0.35
CYP2C9 P11712 1/20 0.35
GSTA1 P08263 1/20 0.35
GSTP1 P09211 1/20 0.35
LMNA P02545 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
NR1H2 P55055 1/20 0.34
RNASEL Q05823 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALOX5 P09917 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25329616 0.90 LTA4H (0.38) LTA4HNR5A1THRATHRBESR1
SCHEMBL25329604 0.89 LTA4H (0.37) LTA4HNR5A1THRATHRBESR1
SCHEMBL5586608 0.88 LTA4H (0.39) LTA4HNR5A1THRATHRBESR1
SCHEMBL5590537 0.88 LTA4H (0.39) LTA4HNR5A1THRATHRBESR1
SCHEMBL25329550 0.87 LTA4H (0.35) LTA4HTLR4CYP2C9GSTA1GSTP1
SCHEMBL25329527 0.86 LTA4H (0.40) LTA4HNR5A1THRATHRBESR1
SCHEMBL28974851 0.85 LTA4H (0.37) LTA4HNR5A1THRATHRBESR1
SCHEMBL5590755 0.82 NR5A1 (0.42) LTA4HNR5A1THRATHRBESR1
SCHEMBL5589121 0.81 NR5A1 (0.44) LTA4HNR5A1THRATHRBESR1
SCHEMBL5587773 0.81 NR5A1 (0.44) LTA4HNR5A1THRATHRBESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583813-B2 Polymerization inhibitors BASF SE (DE) 2026-03-24 US disclosed
US-20230242472-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242472-A1 POLYMERIZATION INHIBITORS RCE1, CABLES1, DPYD LTA4H 1432/4885NR5A1 3880/4885THRA 4834/4885
US-12583813-B2 Polymerization inhibitors PTGS1, PTGER1, POT1 LTA4H 323/4885NR5A1 2231/4885THRA 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.